Articles with public access mandates - Keith A Johnson - National Institute for Health Research, UKLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallFWODFGSFIDSTFWFFNRSNIHGovernment of ItalyGovernment of SpainNSFCFCTSTFCEuropean CommissionAcademy of FinlandDOECSIRNSFNKFIBELSPOMESTDMTAOTKACASHelmholtzBMBFTUBITAKSNSFNCNCIHRDoDFAPESPMRCNHMRCNIHRSwedish Research CouncilARCNSERCHHMIWellcomeFRQSNWOUK Research & InnovationKnut and Alice Wallenberg FoundationGovernment of ArgentinaDFFDNRFNRFARRSRCNDoris Duke Charitable FoundationResearch Grants Council, Hong KongRoyal Society UKParkinson's Foundation, USAAHAGenome CanadaINSERMMarianne and Marcus Wallenberg FoundationAlzheimers's UKBBSRCEPSRCZonMwANRUSAIDHSFBanking Foundation "la Caixa"HRBCancer Research UKCanada First Research Excellence FundGatesFordNASAVAEMBLBHFDMTState of CalifoniaFRQNTNMRCMichael J Fox FoundationMQ Mental Health ResearchCZI
Not available based on mandate: 1
Amplification, not spreading limits rate of tau aggregate accumulation in Alzheimer’s disease
G Meisl, Y Zuo, K Allinson, T Rittman, S DeVos, JS Sanchez, CK Xu, ...
bioRxiv, 2020.11. 16.384727, 2020
Available based on mandate: 13
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
Brain charts for the human lifespan
RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ...
Nature 604 (7906), 525-533, 2022
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ...
Cell reports 35 (13), 2021
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ...
The Lancet Public Health 6 (5), e335-e345, 2021
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ...
Neurology 85 (8), 692-700, 2015
Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease
Z Chen, D Mengel, A Keshavan, RA Rissman, A Billinton, M Perkinton, ...
Alzheimer's & Dementia 15 (3), 487-496, 2019
Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageing
JP Chhatwal, AP Schultz, KA Johnson, T Hedden, S Jaimes, ...
Brain 141 (5), 1486-1500, 2018
In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease
G Meisl, E Hidari, K Allinson, T Rittman, SL DeVos, JS Sanchez, CK Xu, ...
Science advances 7 (44), eabh1448, 2021
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ...
Iscience 24 (11), 2021
Quantitative amyloid imaging in autosomal dominant Alzheimer’s disease: results from the DIAN study group
Y Su, TM Blazey, CJ Owen, JJ Christensen, K Friedrichsen, ...
PLoS One 11 (3), e0152082, 2016
White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease
S Lee, ME Zimmerman, A Narkhede, SE Nasrabady, G Tosto, IB Meier, ...
PLoS One 13 (5), e0195838, 2018
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
SA Schultz, JF Strain, A Adedokun, Q Wang, O Preische, J Kuhle, S Flores, ...
Neurobiology of disease 142, 104960, 2020
Correction: quantitative amyloid imaging in autosomal dominant Alzheimer’s disease: results from the DIAN study group
Y Su, TM Blazey, CJ Owen, JJ Christensen, K Friedrichsen, ...
Plos one 11 (9), e0163669, 2016
Publication and funding information is determined automatically by a computer program